Max V. Ranall

879 total citations
13 papers, 688 citations indexed

About

Max V. Ranall is a scholar working on Molecular Biology, Oncology and Otorhinolaryngology. According to data from OpenAlex, Max V. Ranall has authored 13 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Otorhinolaryngology. Recurrent topics in Max V. Ranall's work include CRISPR and Genetic Engineering (3 papers), Virus-based gene therapy research (2 papers) and DNA Repair Mechanisms (2 papers). Max V. Ranall is often cited by papers focused on CRISPR and Genetic Engineering (3 papers), Virus-based gene therapy research (2 papers) and DNA Repair Mechanisms (2 papers). Max V. Ranall collaborates with scholars based in Australia, United States and Canada. Max V. Ranall's co-authors include David S. Guttman, Sara F. Sarkar, Jean T. Greenberg, Gregory C Kettler, Boris A. Vinatzer, Brian Gabrielli, Thomas J. Gonda, Paul Leo, Mark A. T. Blaskovich and Mark S. Butler and has published in prestigious journals such as Science, PLoS ONE and Cancer Research.

In The Last Decade

Max V. Ranall

13 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Max V. Ranall Australia	11	278	272	131	65	46	13	688
Nikola Valkov United States	13	369 1.3×	63 0.2×	161 1.2×	30 0.5×	31 0.7×	20	623
Olesya O. Panasenko Switzerland	21	1.1k 3.8×	67 0.2×	96 0.7×	124 1.9×	49 1.1×	35	1.2k
Sergey Tcherniuk France	14	390 1.4×	50 0.2×	130 1.0×	127 2.0×	44 1.0×	21	696
Shui‐Tsung Chen Taiwan	10	214 0.8×	45 0.2×	72 0.5×	29 0.4×	29 0.6×	11	491
Chengliang Wang China	15	389 1.4×	51 0.2×	44 0.3×	60 0.9×	23 0.5×	37	529
Varandt Y. Khodaverdian United States	4	443 1.6×	58 0.2×	51 0.4×	94 1.4×	32 0.7×	8	526
Isabelle Hatin France	19	1.1k 4.0×	53 0.2×	141 1.1×	30 0.5×	110 2.4×	40	1.4k
Nikolas Gunkel Germany	18	471 1.7×	33 0.1×	107 0.8×	29 0.4×	45 1.0×	25	769
Gregory LaMonte United States	11	476 1.7×	63 0.2×	70 0.5×	41 0.6×	24 0.5×	12	822

Countries citing papers authored by Max V. Ranall

Since Specialization

Citations

This map shows the geographic impact of Max V. Ranall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max V. Ranall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max V. Ranall more than expected).

Fields of papers citing papers by Max V. Ranall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max V. Ranall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max V. Ranall. The network helps show where Max V. Ranall may publish in the future.

Co-authorship network of co-authors of Max V. Ranall

This figure shows the co-authorship network connecting the top 25 collaborators of Max V. Ranall. A scholar is included among the top collaborators of Max V. Ranall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max V. Ranall. Max V. Ranall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Brand, Toni M., Stefan Hartmann, Neil E. Bhola, et al.. (2018). Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer. Cancer Research. 78(9). 2383–2395. 31 indexed citations

Brand, Toni M., Stefan Hartmann, Neil E. Bhola, et al.. (2016). Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ Patients. Clinical Cancer Research. 23(12). 3072–3083. 44 indexed citations

Lee, Won‐Jae, Dubravka Škalamera, Max V. Ranall, et al.. (2016). Genome-Wide Overexpression Screen Identifies Genes Able to Bypass p16-Mediated Senescence in Melanoma. SLAS DISCOVERY. 22(3). 298–308. 8 indexed citations

Gabrielli, Brian, Max V. Ranall, Zay Yar Oo, et al.. (2015). Aurora A Is Critical for Survival in HPV-Transformed Cervical Cancer. Molecular Cancer Therapeutics. 14(12). 2753–2761. 35 indexed citations

Huang, Johnny X., Geraldine Kaeslin, Max V. Ranall, et al.. (2015). Evaluation of biomarkers for in vitro prediction of drug‐induced nephrotoxicity: comparison ofHK‐2, immortalized human proximal tubule epithelial, and primary cultures of human proximal tubular cells. Pharmacology Research & Perspectives. 3(3). e00148–e00148. 52 indexed citations

Brooks, Kelly, Max V. Ranall, Loredana Spoerri, et al.. (2014). Decatenation checkpoint‐defective melanomas are dependent on PI3K for survival. Pigment Cell & Melanoma Research. 27(5). 813–821. 10 indexed citations

Škalamera, Dubravka, et al.. (2012). Generation of a Genome Scale Lentiviral Vector Library for EF1α Promoter-Driven Expression of Human ORFs and Identification of Human Genes Affecting Viral Titer. PLoS ONE. 7(12). e51733–e51733. 22 indexed citations

Brooks, Kelly, Vanessa Oakes, Max V. Ranall, et al.. (2012). A potent Chk1 inhibitor is selectively cytotoxic in melanomas with high levels of replicative stress. Oncogene. 32(6). 788–796. 72 indexed citations

Ranall, Max V., Mark S. Butler, Mark A. T. Blaskovich, & Matthew A. Cooper. (2012). Resolving Biofilm Infections: Current Therapy and Drug Discovery Strategies. Current Drug Targets. 13(11). 1375–1385. 21 indexed citations

10.

Škalamera, Dubravka, Max V. Ranall, Paul Leo, et al.. (2011). A High-Throughput Platform for Lentiviral Overexpression Screening of the Human ORFeome. PLoS ONE. 6(5). e20057–e20057. 41 indexed citations

11.

Ranall, Max V., Brian Gabrielli, & Thomas J. Gonda. (2011). High-Content Imaging of Neutral Lipid Droplets with 1,6-Diphenylhexatriene. BioTechniques. 51(1). 35–42. 25 indexed citations

12.

Ranall, Max V., Brian Gabrielli, & Thomas J. Gonda. (2010). Adaptation and validation of DNA synthesis detection by fluorescent dye derivatization for high-throughput screening. BioTechniques. 48(5). 379–386. 11 indexed citations

13.

Guttman, David S., Boris A. Vinatzer, Sara F. Sarkar, et al.. (2002). A Functional Screen for the Type III (Hrp) Secretome of the Plant Pathogen Pseudomonas syringae. Science. 295(5560). 1722–1726. 316 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact